Initial Experience with Transition to a “Test and Treat” ART Strategy: San Francisco

A “test and treat” antiretroviral therapy strategy decreased time from diagnosis of HIV infection to virologic suppression; nonetheless, key groups remained less likely to achieve suppression.

In 2010, the San Francisco Department of Public Health implemented a “test and treat” antiretroviral therapy strategy at all publicly funded clinics. To measure success with that more aggressive approach, researchers analyzed data from the San Francisco HIV/AIDS case registry for individuals aged ≥13 who had received a new diagnosis of HIV infection between 2008 and 2012 (n=2349). In addition, to examine disparities in achieving virologic suppression, they analyzed data on patients aged ≥13 who were alive as of December 31, 2012 (≥1 year after diagnosis), were still residing in San Francisco, and had HIV-related laboratory tests reported (n=11,787).

Between 2008 and 2012, the median time from new HIV diagnosis to virologic suppression decrea…

Reviewing Author

Keith Henry, MD

Disclosures

Consultant/Advisory BoardViiV Advisory Board

Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes

Keith Henry, MD

Disclosures

Consultant/Advisory BoardViiV Advisory Board

Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes

Initial Experience with Transition to a “Test and Treat” ART Strategy: San Francisco

Topics

Reviewing Author